Treatment-related myelodysplasia/AML in a patient with a history of breast cancer and an oligodendroglioma treated with temozolomide: Case study and review of the literature1
Open Access
- 1 July 2006
- journal article
- case report
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 8 (3), 280-283
- https://doi.org/10.1215/15228517-2006-003
Abstract
The emergence of temozolomide as an effective alkylating agent with little acute toxicity or cumulative myelosuppression has led to protracted courseKeywords
This publication has 13 references indexed in Scilit:
- New trends in umbilical cord blood transplantationBlood, 2005
- Treatment-related myelodysplastic syndrome after temozolomide for recurrent high-grade gliomaJournal of Neuro-Oncology, 2005
- Temozolomide As Initial Treatment for Adults With Low-Grade Oligodendrogliomas or Oligoastrocytomas and Correlation With Chromosome 1p DeletionsJournal of Clinical Oncology, 2004
- Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago seriesBlood, 2003
- Therapy-related myelodysplastic syndrome (t-MDS) in a patient with anaplastic astrocytoma: successful treatment with allogeneic bone marrow transplant.Journal of Neuro-Oncology, 2001
- World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997Journal of Clinical Oncology, 1999
- Phase I dose-escalation and pharmacokinetic study of temozolomide (SCH 52365) for refractory or relapsing malignanciesBritish Journal of Cancer, 1999
- Acute leukemia following treatment of malignant gliomaJournal of Neuro-Oncology, 1998
- Bone marrow transplantation for therapy-related myelodysplasia: comparison with primary myelodysplasiaBone Marrow Transplantation, 1997
- Two cases of acute leukemia following treatment of malignant gliomaCancer, 1983